ヨーロッパとルーマニアにおける子宮頸がんのスクリーニング:政策の見直し,進展,そして持続的な格差
Gabriel Marian Saveliev1,2, Valentin Nicolae Varlas2,3, Madalina Piron-Dumitrascu1,2
1Alessandrescu-Rusescu National Institute for Mother and Child Health, Bucharest, Romania.
Journal of medicine and life
|September 2, 2025
まとめ
ヒトパピローマウイルス (HPV) ワクチン接種率が低いため,ルーマニアはEUで最も高い子宮頸がん率を有しています. システム上の改革は,ヨーロッパ全域の健康格差の予防と削減に不可欠です.
科学分野:
- 公衆衛生
- 腫瘍学
- エピデミオロジー
背景:
- 子宮頸がんは世界の女性の主要な死因であり, HPVワクチン接種とスクリーニングで予防できます.
- ヨーロッパで進歩しているにもかかわらず,ルーマニアは,EUの中で最も高い子宮頸がんの発生率と死亡率を示しています.
研究 の 目的:
- ルーマニアの課題を中心に,ヨーロッパの子宮頸がんスクリーニング政策を評価する.
- 障害を特定し,ルーマニアとヨーロッパ全土で 子宮頸がん予防を改善するための戦略を提案する.
主な方法:
- PubMed,Web of Science,Embase,Google Scholarからの研究について解説しています.
- HPVワクチン接種,スクリーニング方法 (細胞学,HPVベースの),プログラム実施,公衆衛生戦略に関するデータの分析.
主要な成果:
- 組織的なスクリーニングと高いHPVワクチン接種率を持つヨーロッパ諸国 (例えばオランダ,英国) は低い割合を示しています.
- ルーマニアは,認識の低さ,インフラ不足,スクリーニング参加率の低さ (<20%),およびHPVワクチン接種率の低さなどの障害に直面しています.
- ルーマニアの国家政策は断片化され,WHO/EUの戦略と一致していない.
結論:
- ルーマニアの高い子宮頸がんの負担は,予防の重要な欧州の格差を強調しています.
- 緊急の改革が必要:HPVスクリーニングへの移行,ワクチン接種の拡大,自己検診の選択肢,公衆教育の強化
- 欧州がん対策計画などのEUイニシアチブと統合することで,進歩を加速し,公平性を促進できます.
関連する概念動画
Principles of Disease Surveillance
180
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
180
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
International Nursing Organizations II
1.1K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448


